Loading…
Based on limited metadata, this FDA Warning Letter issued to Torrent Pharma Inc on October 28, 2019 addresses compliance issues related to drug manufacturing or distribution. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product oversight, though the specific issuing office and detailed violation count are not provided in this metadata summary.